Skip to main content

Table 1 Percent differences between converted absorbed doses and [211At]MABG [8] absorbed dose

From: Nonclinical study and applicability of the absorbed dose conversion method with a single biodistribution measurement for targeted alpha-nuclide therapy

Organ or tissue Converted by [131I]MIBG [8] [211At]MABG [9] [125I]MBBG [10] [77Br]MBBG [10]
Heart HL − 19 21 − 11 3
HL+
RAP
10 − 7 − 5 − 5
Liver HL − 21 4 − 29 − 30
HL+
RAP
10 − 10 1 1
Kidney HL − 29 − 14 − 53 − 53
HL+
RAP
10 − 9 1 − 1
Intestine HL − 6 19 − 20 − 22
HL+
RAP
3 − 16 − 9 − 8
Blood HL − 36 13 2 5
HL+
RAP
12 − 2 2 − 2
Stomach HL − 4 69 20 65
HL+
RAP
− 1 − 1 0 0
Adrenals HL − 57 − 16 − 51 − 65
HL+
RAP
10 − 8 − 2 − 2
Tumor HL − 17 797 569 694
HL+
RAP
− 1 0 − 1 − 1
Average HL − 23 112 53 74
HL+
RAP
7 − 7 − 2 − 2